Cargando…
Magnetic nanoparticles of Fe(3)O(4) enhance docetaxel-induced prostate cancer cell death
Docetaxel (DTX) is one of the most important anticancer drugs; however, the severity of its adverse effects detracts from its practical use in the clinic. Magnetic nanoparticles of Fe(3)O(4) (MgNPs-Fe(3)O(4)) can enhance the delivery and efficacy of anticancer drugs. We investigated the effects of M...
Autores principales: | Sato, Akiko, Itcho, Naoki, Ishiguro, Hitoshi, Okamoto, Daiki, Kobayashi, Naohito, Kawai, Kazuaki, Kasai, Hiroshi, Kurioka, Daisuke, Uemura, Hiroji, Kubota, Yoshinobu, Watanabe, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753150/ https://www.ncbi.nlm.nih.gov/pubmed/23990723 http://dx.doi.org/10.2147/IJN.S40766 |
Ejemplares similares
-
Effects of Fe(3)O(4) Magnetic Nanoparticles on A549 Cells
por: Watanabe, Masatoshi, et al.
Publicado: (2013) -
Identification of miR-30d as a novel prognostic maker of prostate cancer
por: Kobayashi, Naohito, et al.
Publicado: (2012) -
Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel
por: Kawahara, Takashi, et al.
Publicado: (2012) -
Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013) -
Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer
por: Uemura, Koichi, et al.
Publicado: (2016)